Skip to content

Braincare BcAc-AF-1000

by Braincare Desenvolvimento E Inovacao Tecnologica SA 12 variants

Braincare BcAc-AF-1000 is a Class II device made by Braincare Desenvolvimento E Inovacao Tecnologica SA, cleared under FDA 510(k) K201989 on 8 Oct 2021 and listed in FDA GUDID since 11 Aug 2023 (UDI-DI 07908398200145), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K201989

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07908398200145 UDI-DI Date11 Aug 2023ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK201989 Date8 Oct 2021DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K201989 decided 8 Oct 2021 Active
  • FDA GUDID UDI-DI 07908398200145 listed 11 Aug 2023 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K201989
  2. Listed FDA GUDID 07908398200145

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Braincare
Generic name
Intracranial pressure monitor
Model / reference
BcAc-AF-1000
Primary DI / UDI-DI
07908398200145
510(k) Number
FDA product code
GWM
GMDN term
Intracranial pressure monitor
Device class
Class II
Regulation number
882.1620
GUDID distribution status
In Commercial Distribution
MRI safety
MR Unsafe
Size
Length — 426 Millimeter
Width — 20 Millimeter

Other devices from Braincare Desenvolvimento E Inovacao Tecnologica SA

See all devices from Braincare Desenvolvimento E Inovacao Tecnologica SA →

Properties

  • Prescription use
  • Lot / batch number
  • Manufacturing date
Other properties (12, all answered No)